Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Starling Oncology, Inc. (STLN) had Tangible Shareholders Equity of $-41.73M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$161.28M |
|
$-9.79M |
|
$134.12M |
|
$27.16M |
|
$165.90M |
|
$-4.62M |
|
$-5.17M |
|
$-9.79M |
|
$-9.79M |
|
$-9.79M |
|
$-9.79M |
|
$-9.79M |
|
$-9.79M |
|
$-4.62M |
|
$-1.52M |
|
103.03M |
|
103.03M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$128.99M |
|
$10.58M |
|
$49.24M |
|
$178.23M |
|
$94.94M |
|
$79.87M |
|
$108.21M |
|
$203.15M |
|
$-24.91M |
|
|
Tangible Shareholders Equity |
$-41.73M |
$-24.91M |
|
100.47M |
|
| Cash Flow Statement Financials | |
$9.72M |
|
$-1.95M |
|
$-0.25M |
|
$33.56M |
|
$41.09M |
|
$7.53M |
|
$2.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.36 |
|
-- |
|
-- |
|
1.45 |
|
-3.21 |
|
16.84% |
|
-2.86% |
|
-2.86% |
|
-- |
|
-6.07% |
|
-6.07% |
|
$7.78M |
|
-- |
|
-- |
|
-- |
|
0.90 |
|
6.70 |
|
2.42 |
|
37.23 |
|
39.29% |
|
23.46% |
|
-5.49% |
|
-17.81% |
|
$-0.25 |
|
$0.08 |
|
$0.09 |
|